Biotech Company, Amgen has announced the National Medical Products Administration (NMPA) approval of a new ind...
Led by the Shanghai Branch of PICC Health Insurance and the Shanghai MediTrust Health as well as supported by Pfiz...
Merck, a leading science and technology company, signed a strategic collaboration agreement with Tencent, a leading prov...
China-based clinical stage biopharmaceutical company, I-Mab Biopharma, exclusively focused on the development of innovat...
Beijing-based Immunochina Pharmaceuticals recently announced the closing of its $20.4 million Series C financing. This ...
iKang Healthcare Group, Inc., a major provider in China’s fast growing private preventive healthcare services mark...
CHINA AID 2019, hosted by Shanghai Intex Exhibition Co., Ltd., is taking place from Wednesday 11th to Friday 1...
AOTI Inc. has entered into a major strategic relationship with a leading Chinese medical company, Nanning Xinzizhu Tradi...
Luye Pharma has entered an agreement with AstraZeneca China, the terms of which grant AstraZeneca China exclusive rights...
CANbridge Pharmaceuticals Inc., a biopharmaceutical company developing innovative drug candidates to treat underserved m...
ZhongAn Online P&C Insurance Co., Ltd. ("ZhongAn" or "ZA Insurance"), the first Internet-based insurer in China...
Innovent Biologics, a world-class biopharmaceutical company that develops and commercializes high quality medicines has ...
Lianluo Smart Limited, a China based professional smart service and products provider has announced its weara...
Ironwood Pharmaceuticals, Inc., a US based commercial biotechnology company, has announced that the National Medical Pro...
Apollomics, Inc. (previously CBT Pharmaceuticals, Inc.), an innovative biopharmaceutical company committed to the discov...
Ascletis Pharma Inc. and Suzhou Alphamab Co., Ltd. (Alphamab) jointly announce that Ascletis' subsidiary and Alphamab ha...
Ping An Insurance (Group) Company of China, Ltd. has announced that the Ping An Global Voyager Fund, has invested in AI ...
Spero Therapeutics, Inc., a multi-asset clinical-stage biopharmaceutical company focused on identifying, developing and ...
